Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Platform adaptive embedded trial for acute respiratory distress syndrome (PETARDS) is a
randomized, embedded, multifactorial, adaptive platform trial for ARDS. The study aimed to
assess the impact of multiple interventions on outcomes in patients with ARDS admitted to the
ICU.
Phase:
Phase 4
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators:
Fudan University Guangdong Provincial People's Hospital Ningbo No. 1 Hospital Peking Union Medical College Hospital Renmin Hospital of Wuhan University Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University The First Affiliated Hospital of Zhengzhou University The Second Affiliated Hospital of Harbin Medical University West China Hospital Wuhan Union Hospital, China